Characterizing mutant intermediate Fabs to probe affinity maturation in the HIV-1 CH103 broadly neutralizing antibody lineage
2019
- 2Usage
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Usage2
- Abstract Views2
Thesis / Dissertation Description
Understanding affinity maturation of antibodies of great breadth that can target many variants of HIV-1 is important for the development of potential vaccine strategies. To this end, we probed affinity maturation of the CH103 broadly neutralizing antibody (bnAb) clonal lineage using wild-type antigen-binding fragments (Fabs) and I3.2 mutant Fabs. Fabs are derived from the CH103 bnAb lineage, and have mutations found at the interface between the variable heavy chain (V_(H)) and the variable light chain (V_(L)) that likely contributed to the development of breadth. In this lineage, the variable light chain shifted away from gp120 over the course of affinity maturation in order to accommodate insertion mutations in a variable loop, called V5, of the HIV Env, a protein involved in membrane fusion and thus infection. We crystallized mutants to confirm that residues at the V_(H) – V_(L) interface contributed to the shift in orientation. In addition to the V_(H) – V_(L) shift observed, the lineage also had altered stability throughout affinity maturation. The results demonstrate the importance of residues located outside the antigen-binding site in affinity maturation.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know